Level Four Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.23M | Buy |
30,368
+1,355
| +5% | +$190K | 0.14% | 191 |
|
|
2025
Q4 | $3.56M | Buy |
29,013
+2,103
| +8% | +$256K | 0.12% | 210 |
|
|
2025
Q3 | $2.99M | Buy |
26,910
+585
| +2% | +$66.5K | 0.1% | 223 |
|
|
2025
Q2 | $2.92M | Sell |
26,325
-7,945
| -23% | -$846K | 0.11% | 220 |
|
|
2025
Q1 | $3.84M | Buy |
34,270
+400
| +1% | +$41.3K | 0.16% | 176 |
|
|
2024
Q4 | $3.13M | Sell |
33,870
-185
| -0.5% | -$16.7K | 0.13% | 187 |
|
|
2024
Q3 | $3.02M | Buy |
34,055
+1,741
| +5% | +$133K | 0.13% | 190 |
|
|
2024
Q2 | $2.22M | Buy |
32,314
+29,001
| +875% | +$1.94M | 0.1% | 220 |
|
|
2024
Q1 | $268K | Hold |
3,313
| – | – | 0.01% | 640 |
|
|
2023
Q4 | $268K | Sell |
3,313
-517
| -13% | -$40.2K | 0.02% | 639 |
|
|
2023
Q3 | $287K | Sell |
3,830
-625
| -14% | -$48.1K | 0.02% | 584 |
|
|
2023
Q2 | $343K | Sell |
4,455
-440
| -9% | -$35.1K | 0.02% | 585 |
|
|
2023
Q1 | $406K | Sell |
4,895
-15
| -0.3% | -$1.24K | 0.03% | 490 |
|
|
2022
Q4 | $422K | Buy |
4,910
+954
| +24% | +$75.5K | 0.03% | 429 |
|
|
2022
Q3 | $244K | Sell |
3,956
-1,454
| -27% | -$91.7K | 0.02% | 467 |
|
|
2022
Q2 | $334K | Buy |
5,410
+245
| +5% | +$15.2K | 0.03% | 431 |
|
|
2022
Q1 | $307K | Sell |
5,165
-1,524
| -23% | -$97.4K | 0.02% | 511 |
|
|
2021
Q4 | $486K | Buy |
6,689
+1,450
| +28% | +$99.9K | 0.04% | 392 |
|
|
2021
Q3 | $366K | Sell |
5,239
-4,510
| -46% | -$317K | 0.04% | 350 |
|
|
2021
Q2 | $671K | Buy |
9,749
+2,279
| +31% | +$152K | 0.05% | 337 |
|
|
2021
Q1 | $483K | Buy |
7,470
+2,438
| +48% | +$157K | 0.04% | 389 |
|
|
2020
Q4 | $293K | Sell |
5,032
-656
| -12% | -$39.6K | 0.02% | 472 |
|
|
2020
Q3 | $359K | Sell |
5,688
-502
| -8% | -$34.8K | 0.03% | 406 |
|
|
2020
Q2 | $478K | Buy |
6,190
+1,862
| +43% | +$143K | 0.04% | 370 |
|
|
2020
Q1 | $326K | Buy |
4,328
+124
| +3% | +$8.57K | 0.04% | 377 |
|
|
2019
Q4 | $286K | Sell |
4,204
-354
| -8% | -$23.1K | 0.01% | 473 |
|
|
2019
Q3 | $289K | Sell |
4,558
-884
| -16% | -$57.8K | 0.03% | 408 |
|
|
2019
Q2 | $368K | Sell |
5,442
-863
| -14% | -$56.8K | 0.04% | 377 |
|
|
2019
Q1 | $411K | Sell |
6,305
-1,704
| -21% | -$113K | 0.05% | 347 |
|
|
2018
Q4 | $501K | Sell |
8,009
-1,412
| -15% | -$98.7K | 0.06% | 293 |
|
|
2018
Q3 | $727K | Sell |
9,421
-2,179
| -19% | -$165K | 0.08% | 267 |
|
|
2018
Q2 | $821K | Buy |
11,600
+1,092
| +10% | +$77.1K | 0.06% | 276 |
|
|
2018
Q1 | $792K | Buy |
10,508
+201
| +2% | +$16K | 0.06% | 272 |
|
|
2017
Q4 | $738K | Sell |
10,307
-705
| -6% | -$53.5K | 0.06% | 295 |
|
|
2017
Q3 | $892K | Buy |
11,012
+644
| +6% | +$49.2K | 0.08% | 239 |
|
|
2017
Q2 | $689K | Sell |
10,368
-108
| -1% | -$7.19K | 0.11% | 205 |
|
|
2017
Q1 | $696K | Sell |
10,476
-1,644
| -14% | -$116K | 0.07% | 265 |
|
|
2016
Q4 | $868K | Buy |
+12,120
| New | +$901K | 0.11% | 190 |
|
Other funds holding GILD
VCM
VPM
Level Four Advisory Services's GILD Position: Q1 2026 in Review
Level Four Advisory Services increased its Gilead Sciences (GILD) stake by 4.7% in Q1 2026, buying an estimated $190K and bringing the position to 30,368 shares worth $4.23M. The position accounts for 0.14% of the portfolio, ranked #191.
Level Four Advisory Services first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Level Four Advisory Services held 30,368 shares of Gilead Sciences worth $4.23M as of Q1 2026.
- Level Four Advisory Services bought 1,355 Gilead Sciences shares in Q1 2026, an estimated $190K.
- Gilead Sciences made up 0.14% of Level Four Advisory Services's portfolio in Q1 2026, its #191 holding.
- Level Four Advisory Services first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.